Europe Constrained Peptide Drugs Market Analysis and Forecast, 2024-2040: Market to Grow by Over $6.5 Billion at a CAGR of 41.55%, Driven by Innovative Pipeline Drugs that Target More than Receptors
February 06, 2024 08:58 ET
|
Research and Markets
Dublin, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The "Europe Constrained Peptide Drugs Market: Analysis and Forecast, 2024-2040" report has been added to ResearchAndMarkets.com's offering.The market size...
Global Constrained Peptide Drugs Market Outlook 2024-2030: Key Insights Into Peptide Type and End-user Trends
January 29, 2024 06:45 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Global Constrained Peptide Drugs Market by Peptide Type (Macrocyclic, Stapled), End-User (Hospitals & Clinics, Pharmaceutical Companies) - Forecast...
Global Peptide Cancer Drug Market 2023: New Technological Innovations Drive Growth
July 06, 2023 05:23 ET
|
Research and Markets
Dublin, July 06, 2023 (GLOBE NEWSWIRE) -- The "Global Peptide Cancer Drug Market, Dosage, Price, Sales and Clinical Trials Insight 2029" report has been added to ResearchAndMarkets.com's...
Constrained Peptide Drugs Global Market 2023: Sector is Expected to Reach $17.28 Billion by 2030 at a CAGR of 38.94%
June 09, 2023 09:03 ET
|
Research and Markets
Dublin, June 09, 2023 (GLOBE NEWSWIRE) -- The "Constrained Peptide Drugs Market - A Global and Regional Analysis: Focus on Peptide Type, Product, and Region-Wise Analysis - Analysis and Forecast,...